{"id":"W4306818192","doi":"10.1136/jnnp-2022-330104","title":"Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Journal of Neurology Neurosurgery & Psychiatry","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Intégré de Santé et de Services Sociaux des Laurentides; Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Cladribine; Ocrelizumab; Medicine; Natalizumab; Fingolimod; Multiple sclerosis; Expanded Disability Status Scale; Internal medicine; Teriflunomide; Ofatumumab; Hazard ratio; Confidence interval; Rituximab; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005863412,0.0005890813,0.001196567,0.0005188962,0.0002911188,0.00105696,0.0006805352,0.001397243,0.002111515],"category_scores_gemma":[0.009526764,0.0003315633,0.003348401,0.0005000134,0.0004449467,0.0007299783,0.0006220749,0.001474301,0.000194331],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00127388,"about_ca_system_score_gemma":0.001007755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002631335,"about_ca_topic_score_gemma":0.001868471,"domain_scores_codex":[0.9967174,0.001515391,0.00029475,0.0006185875,0.0004314024,0.0004224186],"domain_scores_gemma":[0.9918205,0.004167951,0.002670476,0.000424206,0.0002143597,0.0007026338],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6610979,0.003967684,0.2639938,0.0006680067,0.01290771,0.0002091117,0.0003410298,0.002223874,0.001681263,0.0001456695,0.0005158378,0.05224816],"study_design_scores_gemma":[0.0402714,0.1706515,0.7690637,0.0002392216,0.0102997,0.0003479721,0.0002657195,0.005069884,0.001828415,0.0003844748,0.001526034,0.0000520286],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978795,0.001499098,0.00009090648,0.00007102363,0.00003579849,0.00005700393,0.000124405,0.000004657278,0.0002377079],"genre_scores_gemma":[0.9990249,0.0003466736,0.00005870415,0.00008754696,0.0000443531,0.00004694093,0.0002544393,0.000002243413,0.0001343794],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005863412,"threshold_uncertainty_score":0.03100908,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.101210036012084,"score_gpt":0.3085696790522099,"score_spread":0.2073596430401259,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}